Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, Aug. 05, 2016 (GLOBE NEWSWIRE) -- Virginia Lipke, an International Infection Control Practitioner at Centers for Disease Control and Prevention, has been selected to join the Nursing...
-
DALLAS, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Not only is the Paleo diet a healthier lifestyle choice, as opposed to the modern American diet of fast food and snacks, but it is also an effective path to...
-
HAMPTON, Va., Sept. 28, 2015 (GLOBE NEWSWIRE) -- The Centers for Disease Control and Prevention (CDC) estimate there are 1.2 million people living with Human Immunodeficiency Virus (HIV) in the United...
-
LOS ANGELES, CA--(Marketwired - Jul 23, 2015) - MediaPlatform, Inc. (www.mediaplatform.com), the leading enterprise video and webcasting platform for corporate communications, training and...
-
VANCOUVER, British Columbia, July 17, 2015 (GLOBE NEWSWIRE) -- A study published in The Lancet HIV by the BC Centre for Excellence in HIV/AIDS (BC-CfE) shows expanding Treatment as Prevention®...
-
LAS VEGAS, NV--(Marketwired - Apr 13, 2015) - NAB Show - MediaPlatform, Inc. (www.mediaplatform.com), the leading enterprise video platform enabling on-demand streaming and live rich media...
-
WINNIPEG, Feb. 23, 2015 (GLOBE NEWSWIRE) -- In 2012, researcher Mark Brockman was among five Canadian principal investigators to receive funding through the Canadian HIV Vaccine Research Initiative...
-
TORONTO, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Basic science is helping to inform new discoveries in HIV vaccine research. A Canadian research team is conducting studies to better understand how the immune...
-
LOS ANGELES, CA--(Marketwired - Nov 20, 2014) - MediaPlatform, Inc. (www.mediaplatform.com), the leading enterprise video platform, today announced that its enterprise webcasting product WebCaster...
-
OSLO, NORWAY--(Marketwired - Nov 18, 2014) - Bionor Pharma ASA (OSLO: BIONOR) Treatment with Vacc-4x + Revlimid (lenalidomide) was well tolerated ...